Showing results (1271-1280 of 1,334) with videos related to

Sort By:
Pageof 134
The Journal of Pathology|February 28, 2015
Paediatric nodal marginal zone B-cell lymphadenopathy of the neck: a Haemophilus influenzae-driven immune disorder?Philip M Kluin, Anton W Langerak, Jannetta Beverdam-Vincent, et al.
Trials|June 19, 2026
CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortiumGertjan J L Kaspers, Merlijn van Hamel, Jonas Abrahamsson, et al.
Blood Cancer Discovery|November 15, 2021
Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic IndicatorsMaarten Fornerod, Jing Ma, Sanne Noort, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2023
Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood <i>KMT2A</i>-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study GroupRomy E van Weelderen, Kim Klein, Christine J Harrison, et al.
Nature Genetics|January 24, 2017
Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomesJasmijn D E de Rooij, Cristyn Branstetter, Jing Ma, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2025
Prognostic factors of early mortality in children and adolescents with relapsed/refractory solid tumors participating in dose-finding trials in the targeted and immune therapies era: An ITCC studyFernando Carceller, Francisco Bautista, Harm Van Tinteren, et al.
Blood|May 10, 2011
Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international studyEva A Coenen, Susana C Raimondi, Jochen Harbott, et al.
Blood|June 17, 2009
Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective studyBrian V Balgobind, Susana C Raimondi, Jochen Harbott, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2020
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew D J Pearson, C Michel Zwaan, E Anders Kolb, et al.
Blood Advances|April 15, 2024
Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemiaRomy E van Weelderen, Christine J Harrison, Kim Klein, et al.
Pageof 134